Trade Names: | |
Synonyms: | |
Status: | Approved (1988) |
Entry Type: | Protein |
Molecule Category: | Salt |
UNII: | 75R0U2568I |
Parent Compound: | OCTREOTIDE |
InChI Key | XQEJFZYLWPSJOV-XJQYZYIXSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C51H70N10O12S2 |
Molecular Weight | 1079.31 |
AlogP | None |
Hydrogen Bond Acceptor | None |
Hydrogen Bond Donor | None |
Number of Rotational Bond | None |
Polar Surface Area | None |
Molecular species | None |
Aromatic Rings | None |
Heavy Atoms | None |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Transporter
Primary active transporter
ATP-binding cassette
ABCB subfamily
|
- | 9340 | - | - | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Prader-Willi Syndrome | 3 | D011218 | ClinicalTrials |
Enteritis | 3 | D004751 | ClinicalTrials |
Diabetic Retinopathy | 3 | D003930 | ClinicalTrials |
Malignant Carcinoid Syndrome | 3 | D008303 | ClinicalTrials |
Diarrhea | 3 | D003967 | ClinicalTrials |
Breast Neoplasms | 3 | D001943 | ClinicalTrials |
Pituitary Neoplasms | 2 | D010911 | ClinicalTrials |
Renal Insufficiency | 2 | D051437 | ClinicalTrials |
Congenital Hyperinsulinism | 2 | D044903 | ClinicalTrials |
Lymphoma | 2 | D008223 | ClinicalTrials |
Obesity | 2 | D009765 | ClinicalTrials |
Thymus Neoplasms | 2 | D013953 | ClinicalTrials |
Constipation | 2 | D003248 | ClinicalTrials |
Neuroendocrine Tumors | 2 | D018358 | ClinicalTrials |
Liver Neoplasms | 2 | D008113 | ClinicalTrials |
Intestinal Obstruction | 2 | D007415 | ClinicalTrials |
Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
Resources | Reference |
---|---|
ChEMBL | CHEMBL1200480 |
FDA SRS | 75R0U2568I |
PDB | ??? |
PubChem | 6917964 |